LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines

Zhang,Hai-Shan; Zhao,Jian-Wu; Wang,Hong; Zhang,Han-Yang; Ji,Qiu‑Ye; Meng,Ling-Jie; Xing,Feng-Juan; Yang,Shu-Ting; Wang,Yan

doi:10.3892/mmr.2013.1798

LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines

Authors:
- Hai-Shan Zhang
- Jian-Wu Zhao
- Hong Wang
- Han-Yang Zhang
- Qiu‑Ye Ji
- Ling-Jie Meng
- Feng-Juan Xing
- Shu-Ting Yang
- Yan Wang
View Affiliations

Affiliations: Department of Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Orthopaedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Research Center for Gene Therapy, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Prosthodontics, School of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: November 14, 2013 https://doi.org/10.3892/mmr.2013.1798
Pages: 103-108

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma is a type of malignant bone tumor with high metastasis and poor prognosis. Previous studies have demonstrated the involvement of LIM kinase 1 (LIMK1) in the proliferation of osteosarcoma cells. LIMK1 is overexpressed in human osteosarcoma tissues and cell lines. To further study LIMK1-associated mechanisms, we used shRNA targeted to the LIMK1 gene to block its expression in the osteosarcoma cell lines MG63 and U2OS. Insulin promoted the proliferation of MG63 cells in a time- and dose-dependent manner, however, this insulin induced proliferation was significantly inhibited by transfection of shRNA targeted to the LIMK1 gene, as well as by the PI3K inhibitor LY294002, but not by the mitogen‑activated protein kinase (MAPK) inhibitor PD98059. The level of cofilin phosphorylation was increased significantly following stimulation of insulin for 24 h, indicating the activation of LIMK1. MG63 cell proliferation was also significantly inhibited by 1,25-dihydroxy vitamin D3 (1,25(OH)2D3) in a time-dependent manner. Furthermore, 1,25(OH)2D3 negated the inhibitory effect of LIMK1 shRNA, indicating that LIMK1 is important in the inhibitory pathway of 1,25(OH)2D3. The present study confirms that LIMK1 is important in regulating osteosarcoma cell proliferation via the insulin/PI3K/LIMK1 signaling pathway, thus the development of gene therapy for osteosarcoma targeting LIMK1 is warranted.

View Figures

View References

1	Picci P: Osteosarcoma (osteogenic sarcoma). Orphamet J Rare Dis. 2:623–637. 2007.
2	Yamazaki D, Kurisu S and Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96:379–386. 2005. View Article : Google Scholar : PubMed/NCBI
3	Gamberi G, Benassi MS, Bohling T, et al: C-myc and c-fos in human osteosarcoma, prognostic value of mRNA and protein expression. Oncology. 55:556–563. 1998. View Article : Google Scholar : PubMed/NCBI
4	Wang Y, Shibasaki F and Mizuno K: Calcium signal-induced cofilin dephosphorylation is mediated by Slingshot via calcineurin. J Biol Chem. 280:12683–12689. 2005. View Article : Google Scholar : PubMed/NCBI
5	Tsai WC, Jin JS, Yu JC, et al: CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system. Int J Surg Pathol. 14:127–131. 2006. View Article : Google Scholar : PubMed/NCBI
6	Sebzda T, Saleh Y, Malicka-Blaszkiewicz M, et al: Actin content and actin polymerization in hepatoma Morris 5123 tumor bearing rats after treatment with cysteine protease inhibitor and vitamin E. J Exp Ther Oncol. 5:23–29. 2005.PubMed/NCBI
7	Amsellem V, Kryszke MH, Hervy M, et al: The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Exp Cell Res. 304:443–456. 2005. View Article : Google Scholar : PubMed/NCBI
8	Pavlov D, Muhlrad A, Cooper J, et al: Actin filament severing by cofilin. J Mol Biol. 365:1350–1358. 2007. View Article : Google Scholar : PubMed/NCBI
9	Huang TY, DerMardirossian C and Bokoch GM: Cofilin phosphatases and regulation of actin dynamics. Curr Opin Cell Biol. 18:26–31. 2006. View Article : Google Scholar : PubMed/NCBI
10	Okano I, Hiraoka J, Otera H, et al: Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs. J Biol Chem. 270:31321–31330. 1995. View Article : Google Scholar : PubMed/NCBI
11	Bernard O, Geniatsus S, Kannourakis G and Dringen R: Kiz-1, a protein with LIM zinc finger and kinase domains, is expressed mainly in neurons. Cell Growth Differ. 5:1159–1171. 1994.PubMed/NCBI
12	Wouters CH, Meijers-Heijboer HJ, Eussen BJ, et al: Deletions at chromosome regions 7q11.23 and 7q36 in a patient with Williams syndrome. Am J Med Genet. 102:261–265. 2001. View Article : Google Scholar : PubMed/NCBI
13	Edwards DC, Sanders LC, Bokoch GM and Gill GN: Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol. 1:253–259. 1999. View Article : Google Scholar : PubMed/NCBI
14	Maekawa M, Ishizaki T, Boku S, et al: Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 285:895–898. 1999. View Article : Google Scholar : PubMed/NCBI
15	Ohashi K, Nagata K, Maekawa M, et al: Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem. 275:3577–3582. 2000. View Article : Google Scholar : PubMed/NCBI
16	Kobayashi M, Nishita M, Mishima T, Ohashi K and Mizuno K: MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J. 25:713–726. 2006. View Article : Google Scholar : PubMed/NCBI
17	Okano I, Hiraoka J, Otera H, et al: Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs. J Biol Chem. 270:31321–31330. 1995. View Article : Google Scholar : PubMed/NCBI
18	Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:550–553. 2002. View Article : Google Scholar : PubMed/NCBI
19	Takemura M, Mishima T, Wang Y, et al: Ca2+/calmodulin-dependent protein kinase IV-mediated LIM kinase activation is critical for calcium signal-induced neurite outgrowth. J Biol Chem. 284:28554–28562. 2009.
20	Cheatham B and Kahn CR: Insulin action and the insulin signaling network. Endocr Rev. 16:117–142. 1995.PubMed/NCBI
21	White MF: The insulin signalling system and the IRS proteins. Diabetologia. 40:S2–S17. 1997. View Article : Google Scholar : PubMed/NCBI
22	Wilson C, Vereshchagina N, Reynolds B, et al: Extracellular and subcellular regulation of the PI3K/Akt cassette: new mechanisms for controlling insulin and growth factor signalling. Biochem Soc Trans. 35:219–221. 2007. View Article : Google Scholar : PubMed/NCBI
23	Nishita M, Tomizawa C, Yamamoto M, et al: Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration. J Cell Biol. 171:349–359. 2005. View Article : Google Scholar : PubMed/NCBI
24	Soosairajah J, Maiti S, Wiggan O, et al: Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin. EMBO J. 24:473–486. 2005. View Article : Google Scholar : PubMed/NCBI
25	Takahashi H, Funakoshi H and Nakamura T: LIM-kinase as a regulator of actin dynamics in spermatogenesis. Cytogenet Genome Res. 103:290–298. 2003. View Article : Google Scholar : PubMed/NCBI
26	Davila M, Frost AR, Grizzle WE and Chakrabarti R: LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem. 278:36868–36875. 2003. View Article : Google Scholar
27	Makishima M and Honma Y: Ethacrynic acid and 1 alpha, 25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells. Leuk Res. 20:781–789. 1996. View Article : Google Scholar : PubMed/NCBI
28	Kawa S, Nikaido T, Aoki Y, et al: Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer. 76:884–889. 1997. View Article : Google Scholar : PubMed/NCBI
29	Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia, evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60:2002–2006. 2000.PubMed/NCBI